These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4880891)

  • 1. Wild-type Gross leukemia virus. I. Soluble antigen (GSA) in the plasma and tissues of infected mice.
    Aoki T; Boyse EA; Old LJ
    J Natl Cancer Inst; 1968 Jul; 41(1):89-96. PubMed ID: 4880891
    [No Abstract]   [Full Text] [Related]  

  • 2. Wild-type Gross leukemia virus. 3. Serological tests as indicators of leukemia risk.
    Aoki T; Boyse EA; Old LJ
    J Natl Cancer Inst; 1968 Jul; 41(1):103-10. PubMed ID: 4873848
    [No Abstract]   [Full Text] [Related]  

  • 3. AKR mouse leukemic cells in tissue culture. II. Immunologic studies on the AKR 87 cell line.
    Duś D; Harlozińska A; Skriabin A; Richter R
    Arch Immunol Ther Exp (Warsz); 1976; 24(5):727-40. PubMed ID: 187141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a rapidly growing AKR lymphoblastic cell line maintaining Gross antigens and viral replication.
    Woods WA; Wivel NA; Massicot JG; Chirigos MA
    Cancer Res; 1970 Aug; 30(8):2147-55. PubMed ID: 4918189
    [No Abstract]   [Full Text] [Related]  

  • 5. Wild-type Gross leukemia virus. II. Influence of immunogenetic factors on natural transmission and on the consequences of infection.
    Aoki T; Boyse EA; Old LJ
    J Natl Cancer Inst; 1968 Jul; 41(1):97-101. PubMed ID: 4873850
    [No Abstract]   [Full Text] [Related]  

  • 6. Virus-coded antigens in chemically induced leukemia.
    Pasternak G; Pasternak L
    Boll Ist Sieroter Milan; 1971; 50(3):192-8. PubMed ID: 5004411
    [No Abstract]   [Full Text] [Related]  

  • 7. Wild-type gross leukemia virus: classification of soluble antigens (GSA).
    Aoki T; Herberman RB; Johnson PA; Liu M; Sturm MM
    J Virol; 1972 Dec; 10(6):1208-19. PubMed ID: 4566440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Demonstration of immunological differences between Graffi- and Gross-virus induced mouse leukemias in vivo and in vitro].
    Pasternak G; Hölzer B
    Neoplasma; 1965; 12(4):339-55. PubMed ID: 4285320
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunologic studies in virus-induced mouse and rat leukemia. II. Demonstration of a membrane-bound, group-specific leukemia antigen in Graffi and Gross leukemias of the mouse].
    Micheel B; Pasternak G; Bierwolf D
    Acta Biol Med Ger; 1972; 28(1):167-75. PubMed ID: 4114866
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune complexes localized in the renal glomeruli of AKR mice: the presence of MuLV gs-I and C-type RNA tumor virus gs-3 determinants.
    Markham RV; Sutherland JC; Cimino EF; Drake WP; Mardiney MR
    Rev Eur Etud Clin Biol; 1972; 17(7):690-4. PubMed ID: 4119502
    [No Abstract]   [Full Text] [Related]  

  • 11. [The type specific antigen of Gross leukemia virus in tumors and normal tissues and its identification by immunodiffusion methods].
    Lezhneva OM
    Biull Eksp Biol Med; 1976 Feb; 81(2):217-9. PubMed ID: 819062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of Gross leukemia cell-surface antigens: a kind of antigenic modulation.
    Aoki T; Johnson PA
    J Natl Cancer Inst; 1972 Jul; 49(1):183-92. PubMed ID: 5037434
    [No Abstract]   [Full Text] [Related]  

  • 14. Alteration of skin in gross leukemia. V. Refutation of virus involvement.
    Mariani T; Maruyama Y
    J Natl Cancer Inst; 1974 Dec; 53(6):1661-4. PubMed ID: 4612164
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
    Green WR
    J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H-2-restricted cytolytic T lymphocytes specific for a subclass of AKR endogenous leukemia virus-induced tumors: correlation of tumor cell susceptibility with expression of the gross cell surface antigen.
    Green WR
    J Immunol; 1980 Dec; 125(6):2584-90. PubMed ID: 6159413
    [No Abstract]   [Full Text] [Related]  

  • 18. Group-specific viral antigens in the milk and tissues of mice naturally infected with mammary tumor virus or Gross leukemia virus.
    Nowinski RC; Old LJ; Boyse EA; de Harven E; Geering G
    Virology; 1968 Apr; 34(4):617-29. PubMed ID: 4297122
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunologic studies on Graffi-virus-infected spontaenous Gross leukemia of AKR mice.
    Micheel B; Pasternak G
    Int J Cancer; 1968 Sep; 3(5):603-13. PubMed ID: 4302083
    [No Abstract]   [Full Text] [Related]  

  • 20. The in vitro generation of H-2-restricted cytotoxic T cells to AKR/Gross leukemia virus-induced tumors. I. Requirement for stimulation with allogeneic leukemia cells in vivo.
    Green WR
    J Immunol; 1982 Mar; 128(3):1043-9. PubMed ID: 6976986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.